SCHEMBL6710296

SCHEMBL6710296

O=C(CCCc1ccccc1)Nc1cccc2cc(C(=O)Nc3ccc(Cl)cc3-c3noc(=O)[nH]3)[nH]c12

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ADORA3 P0DMS8 1/20 0.41
MAOB P27338 1/20 0.41
ADORA1 P30542 1/20 0.41
MEN1 O00255 1/20 0.40
KMT2A Q03164 1/20 0.40
GRIK1 P39086 1/20 0.39
ALOX15 P16050 1/20 0.39
MAPK1 P28482 1/20 0.39
HDAC3 O15379 4/20 0.38
HDAC1 Q13547 4/20 0.38
MMP2 P08253 3/20 0.38
MMP13 P45452 3/20 0.38
NPY5R Q15761 1/20 0.38
PLCG2 P16885 1/20 0.37
MMP9 P14780 2/20 0.37
MMP8 P22894 2/20 0.37
HDAC4 P56524 1/20 0.36
HDAC7 Q8WUI4 1/20 0.36
HDAC2 Q92769 1/20 0.36
HDAC10 Q969S8 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6707741 0.98 HDAC1 (0.40) ADORA3MAOBADORA1MEN1KMT2A
SCHEMBL6708940 0.95 ALOX15 (0.44) MEN1KMT2AGRIK1ALOX15MAPK1
SCHEMBL6710256 0.91 RAB9A (0.41) MEN1KMT2AGRIK1HDAC3HDAC1
SCHEMBL6710011 0.91 NPC1 (0.45) MEN1KMT2AGRIK1HDAC3HDAC1
SCHEMBL6709861 0.91 GRIK1 (0.41) MEN1KMT2AGRIK1MAPK1PLCG2
SCHEMBL6710607 0.90 GRIK1 (0.41) GRIK1ALOX15HDAC3HDAC1PLCG2
SCHEMBL6713462 0.90 HDAC3 (0.41) GRIK1ALOX15HDAC3HDAC1PLCG2
SCHEMBL6710059 0.89 HDAC3 (0.42) GRIK1ALOX15HDAC3HDAC1PLCG2
SCHEMBL6756845 0.89 HDAC3 (0.42) GRIK1ALOX15HDAC3HDAC1PLCG2
SCHEMBL6707622 0.89 HDAC1 (0.37) MEN1KMT2AHDAC3HDAC1MMP2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20040142981-A1 Antibacterial benzoic acid derivatives PHARMACIA & UPJOHN COMPANY 2004-07-22 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040142981-A1 Antibacterial benzoic acid derivatives GABRD, PHB1, GABBR1 ADORA3 3118/4885MAOB 1290/4885ADORA1 2379/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.